Karo Bio, Pfizer deal

Karo Bio and Pfizer extended to the end of 2014 their 2011 deal to discover and develop small molecule RAR-related orphan receptor C ( RORC; RORgamma) modulators to treat autoimmune diseases. Pfizer ...